Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Exchanges through the blood-brain barrier].

J M Scherrmann1

  • 1Laboratoire de Pharmacie Clinique & Pharmacocinétique, Faculté de Pharmacie, 4 avenue de l'Observatoire, F 75006 Paris & INSERM U26, Hôpital Fernand Widal, 200 rue du Faubourg Saint-Denis, F 75010 Paris.

Annales Pharmaceutiques Francaises
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy.

The AAPS journal·2020
Same author

Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.

Antimicrobial agents and chemotherapy·2013
Same author

ABC drug transporter and nuclear receptor expression in human cytotrophoblasts: influence of spontaneous syncytialization and induction by glucocorticoids.

Placenta·2012
Same author

Toxicokinetic-toxicodynamic models describing the relation of plasma and red blood cell potassium with plasma digitalis in acute human digitalis poisoning.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes.

International journal of pharmaceutics·2010
Same author

High levels of P-glycoprotein activity in human lymphocytes in the first 6 months of life.

Clinical pharmacology and therapeutics·2008
Same journal

[Artificial Intelligence in the Pharmaceutical Industry: Governance, Quality, and Regulatory Challenges].

Annales pharmaceutiques francaises·2026
Same journal

No evidence of significant natural environmental exposure to arsenic for Napoleon I on the island of Saint Helena (1815-1821).

Annales pharmaceutiques francaises·2026
Same journal

EFFECTS OF GLP-1 RECEPTOR AGONISTS ON PERIODONTAL TISSUE: AN INTERDISCIPLINARY EVIDENCE MAPPING - SCOPING REVIEW.

Annales pharmaceutiques francaises·2026
Same journal

Regulatory non-compliance of parallel imported medicines in Kenya and implications for public health: Evidence from Nairobi County.

Annales pharmaceutiques francaises·2026
Same journal

Prostaglandin analogues in cosmetic products formulated for eyelash lengthening.

Annales pharmaceutiques francaises·2026
Same journal

Mechanistic and thermodynamic evaluation of sodium citrate-mediated hydrotropism for the biopharmaceutical optimization of BCS Class II drug atorvastatin calcium.

Annales pharmaceutiques francaises·2026
See all related articles

The blood-brain barrier (BBB) controls brain-blood exchange via tight junctions and transporters. It acts as a barrier to drugs and nutrients, with specific mechanisms for macromolecule transport.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Context:

  • The blood-brain barrier (BBB) is a critical interface regulating the passage of substances between the bloodstream and the brain.
  • Specialized features of brain capillary endothelium, including tight junctions and lack of fenestrations, define the BBB's unique properties.
  • The BBB functions as a metabolic and pharmacological barrier due to enzymatic activity and transporter expression in endothelial cells.

Purpose:

  • To elucidate the complex mechanisms governing nutrient and drug exchange across the blood-brain barrier.
  • To highlight the structural and functional đặc điểm contributing to the BBB's barrier function.
  • To explain the role of transporters, such as P-glycoprotein, in drug efflux from the brain.

Summary:

Related Experiment Videos

  • The BBB's integrity is maintained by tight junctions between endothelial cells, preventing paracellular transport.
  • Metabolic enzymes and transporters on brain microvessel endothelial cells contribute to the BBB's barrier properties.
  • Receptor-mediated transcytosis facilitates the transport of macromolecules like insulin, while P-glycoprotein actively effluxes drugs.

    • Impact:

    • Understanding the BBB is crucial for developing effective drug delivery strategies to the brain.
    • The BBB's properties present significant challenges for treating central nervous system disorders.
    • Further research into BBB transport mechanisms can lead to novel therapeutic interventions.